Centermed Sp. z o.o.

Research site

Poland Ul. Wojciecha Bandrowskiego 16 A, 33-100 Tarnow, Poland

3 trials recruiting
Asthma · Chronic obstructive pulmonary disease · Conjunctivitis allergic
Adults and children

About Specializations

Centermed Sp. z o.o. in Tarnow, Poland specialises in clinical trials of conditions such as Asthma, Chronic obstructive pulmonary disease, Conjunctivitis allergic, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Ul. Wojciecha Bandrowskiego 16 A33-100 TarnowPoland

Open in maps ↗

Recruiting now: 3 trials
Conditions studied: 3

More sites in Tarnow Poland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

9 clinical trials

Chronic obstructive pulmonary disease

Recruiting

Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)

Investigational

Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)

Investigational

Poland

Participants:18–64 years · 65+ years
Sponsor:Pfizer Inc.

Contact Research Centre

Asthma

Recruiting

A study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma

Investigational

A study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma

Investigational

Poland

Participants:18–64 years · 65+ years
Sponsor:Kymera Therapeutics Inc.

Contact Research Centre

Asthma

Recruiting

Study on Tezepelumab for Children Aged 5 to 11 with Severe Asthma

Registered drug

Study on Tezepelumab for Children Aged 5 to 11 with Severe Asthma

Registered drug

Poland

Participants:0–17 years
Substances:Tezepelumab
Sponsor:AstraZeneca AB

Contact Research Centre

Conjunctivitis allergic

Not yet recruiting

Study on the Effectiveness and Safety of PQ Birch for Patients with Seasonal Allergic Rhinitis or Rhinoconjunctivitis from Birch Pollen

Investigational

Study on the Effectiveness and Safety of PQ Birch for Patients with Seasonal Allergic Rhinitis or Rhinoconjunctivitis from Birch Pollen

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Placebo
Sponsor:Allergy Therapeutics (UK) Limited

Contact Research Centre

Asthma

Not yet recruiting

Long‑Term Safety and Tolerability Study of Oral KT‑621 in Adults with Uncontrolled Moderate‑to‑Severe Eosinophilic Asthma

InvestigationalNo placebo

Long‑Term Safety and Tolerability Study of Oral KT‑621 in Adults with Uncontrolled Moderate‑to‑Severe Eosinophilic Asthma

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Sponsor:Kymera Therapeutics Inc.

Contact Research Centre

Asthma

Not recruiting

Study on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma

Registered drug

Study on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Atuliflapon
Sponsor:AstraZeneca AB

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Investigational

Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Astegolimab
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Asthma

Not recruiting

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled

Registered drug

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled

Registered drug

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Budesonide
Sponsor:AstraZeneca AB

Contact Research Centre

Asthma

Not recruiting

Study on the Effectiveness and Safety of Benralizumab for Children with Severe Eosinophilic Asthma

Registered drug

Study on the Effectiveness and Safety of Benralizumab for Children with Severe Eosinophilic Asthma

Registered drug

Poland

Participants:0–17 years
Substances:Benralizumab
Sponsor:AstraZeneca AB

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites